About GLP-1
GLP-1 (Glucagon-Like Peptide-1) is an incretin hormone peptide involved in glucose homeostasis and widely used in metabolic research. Supplied as a lyophilized powder for laboratory investigations into incretin signaling, insulin secretion pathway markers, and glucagon regulation mechanisms in controlled experimental models. Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Combination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis.
Recent research on GLP-1: Combination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis.
Read Full Study on PubMedNetwork pharmacology combined with molecular docking to investigate the potential role of curcumin targeting TGR5 to modulate the GLP-1 pathway in T2DM with obesity.
Recent research on GLP-1: Network pharmacology combined with molecular docking to investigate the potential role of curcumin targeting TGR5 to modulate the GLP-1 pathway in T2DM with obesity.
Read Full Study on PubMedAdditional Studies
GLP-1 receptor agonists: A paradigm shift for psychiatry?
Recent research on GLP-1: GLP-1 receptor agonists: A paradigm shift for psychiatry?
Read on PubMedEffect of GLP-1 receptor agonists on upper gastrointestinal endoscopy outcomes: a systematic review and meta-analysis.
Recent research on GLP-1: Effect of GLP-1 receptor agonists on upper gastrointestinal endoscopy outcomes: a systematic review and meta-analysis.
Read on PubMedAvailability, treatment costs and affordability of SGLT-2 inhibitors and GLP-1 RAs for diabetes in 10 countries: a cross-sectional study.
Recent research on GLP-1: Availability, treatment costs and affordability of SGLT-2 inhibitors and GLP-1 RAs for diabetes in 10 countries: a cross-sectional study.
Read on PubMedDistinct brain regions mediate regulation of food intake in response to GIPR agonism or antagonism.
Recent research on GLP-1: Distinct brain regions mediate regulation of food intake in response to GIPR agonism or antagonism.
Read on PubMedCurrent diabetes therapy and use of diabetes technology in people living with cystic fibrosis-related diabetes (CFRD): Insights from the DPV network.
Recent research on GLP-1: Current diabetes therapy and use of diabetes technology in people living with cystic fibrosis-related diabetes (CFRD): Insights from the DPV network.
Read on PubMedFood Industry Engineering Is Less Important Than Access to Gut Microbiota-Accessible Foods for Preventing Chronic Disease.
Recent research on GLP-1: Food Industry Engineering Is Less Important Than Access to Gut Microbiota-Accessible Foods for Preventing Chronic Disease.
Read on PubMedRelated Research
Purchase GLP-1 from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.